Skip to main content
Veterinary Medicines

DIVENCE PENTA (--) - Lyophilisate and solvent for emulsion for injection

Authorised
  • Bovine respiratory syncytial virus, strain Lym-56, Live
  • Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Bovine viral diarrhoea virus 1, E2 protein, recombinant
  • Bovine viral diarrhoea virus 2, E2 protein, recombinant

Product identification

Medicine name:
DIVENCE PENTA (--) - Lyophilisate and solvent for emulsion for injection
Active substance:
  • Bovine respiratory syncytial virus, strain Lym-56, Live
  • Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Bovine viral diarrhoea virus 1, E2 protein, recombinant
  • Bovine viral diarrhoea virus 2, E2 protein, recombinant
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain Lym-56, Live
    Presentation_strength:10⁵·² - 10⁶·⁵ CCID50 Comments:lyophilisate (per dose of 2ml) Index:0
  • Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live
    Presentation_strength:10⁶·³ - 10⁷·⁶ CCID50* Comments:lyophilisate (per dose of 2ml) Index:1
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    Presentation_strength:≥ 20⁶·² EU** Comments:lyophilisate (per dose of 2ml) Index:2
  • Bovine viral diarrhoea virus 1, E2 protein, recombinant
    Presentation_strength:≥ 31.6 EU** Comments:lyophilisate (per dose of 2ml) Index:3
  • Bovine viral diarrhoea virus 2, E2 protein, recombinant
    Presentation_strength:≥ 21.0 EU** Comments:lyophilisate (per dose of 2ml) Index:4
Pharmaceutical form:
  • Lyophilisate and solvent for emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AH
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Lyophilisate: vial (glass); Solvent; vial (PET), Package_size:Lyophlisate: 1 vial + Solvent: 1 vial, Content:Lyophilisate: 10 doses; solvent: 20 ml
  • Packaging:Lyophilisate: vial (glass); Solvent; vial (PET), Package_size:Lyophlisate: 1 vial + Solvent: 1 vial, Content:Lyophilisate: 20 doses; solvent: 40 ml
  • Packaging:Lyophilisate: vial (glass); Solvent; vial (PET), Package_size:Lyophlisate: 1 vial + Solvent: 1 vial, Content:Lyophilisate: 5 doses; solvent: 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra, S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 31/05/2024
Download
Bulgarian (PDF)
Published on: 31/05/2024
Croatian (PDF)
Published on: 31/05/2024
Czech (PDF)
Published on: 31/05/2024
Danish (PDF)
Published on: 31/05/2024
Dutch (PDF)
Published on: 31/05/2024
Estonian (PDF)
Published on: 31/05/2024
Finnish (PDF)
Published on: 31/05/2024
French (PDF)
Published on: 31/05/2024
German (PDF)
Published on: 31/05/2024
Greek (PDF)
Published on: 31/05/2024
Hungarian (PDF)
Published on: 31/05/2024
Icelandic (PDF)
Published on: 31/05/2024
Italian (PDF)
Published on: 31/05/2024
Latvian (PDF)
Published on: 31/05/2024
Lithuanian (PDF)
Published on: 31/05/2024
Maltese (PDF)
Published on: 31/05/2024
Norwegian (PDF)
Published on: 6/06/2024
Polish (PDF)
Published on: 21/06/2024
Portuguese (PDF)
Published on: 31/05/2024
Romanian (PDF)
Published on: 31/05/2024
Slovak (PDF)
Published on: 31/05/2024
Slovenian (PDF)
Published on: 31/05/2024
Spanish (PDF)
Published on: 31/05/2024
Swedish (PDF)
Published on: 31/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."